Mainz Biomed N.V.
MYNZ
$3.07
-$0.15-4.66%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/2/2025
-
Simply Wall St
4/1/2025
-
GuruFocus
4/1/2025
-
The Fly
4/1/2025
-
Globe Newswire
3/27/2025
-
GuruFocus
3/27/2025
-
The Fly
3/27/2025
-
Globe Newswire
3/20/2025
-
Zacks Investment Research
3/13/2025
-
GuruFocus
3/13/2025
-
The Fly
3/13/2025
-
Globe Newswire
3/7/2025
-
Stocktwits News Feed
3/3/2025
-
GuruFocus
3/3/2025
-
TipRanks Financial Blog
3/3/2025
-
The Fly
3/3/2025
-
Globe Newswire
2/20/2025
-
GuruFocus
2/20/2025
-
SeekingAlpha.com: All News
2/20/2025
-
Seeking Alpha - Healthcare
2/20/2025
-
The Fly
2/20/2025
-
Globe Newswire
2/15/2025
-
GuruFocus
2/14/2025
-
The Fly
2/14/2025
-
The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Oct 13 and 17 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
49 6131 554 2860
Address
Robert Koch Strasse 50
Mainz, 55129
Mainz, 55129
Country
Year Founded
Business Description
Sector
Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular...
more